Our Products Pipeline
Diversified Pipeline
Our in-house engine is helping to explore the molecular targets and the development of small molecules for the treatment of various indication.
INDICATION
TARGET
Discovery IND-enabling Phase 1 Phase 2
BPH (prostate)
5 ALPHA
- 92%
Diabetics
Undisclosed
- 15%
HIV/AIDS
Undisclosed
- 15%
Haemorrhoid
Undisclosed
- 15%
Fibroids
Undisclosed
- 15%
Hypertension
Undisclosed
- 15%